Senior CMC Assessor
US Food and Drug Administration/OPQ/Division of Lifecycle API
Barbara O. Scott, M.S., Senior CMC Reviewer, CDER/OPQ/ONDP/DLAPI/Branch I
Barbara joined the Food and Drug Administration (FDA) in 2004 as a chemistry and manufacturing controls (CMC) reviewer for Abbreviated New Drug Applications (ANDA). She is currently a senior CMC assessor in the Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ), Division of Lifecycle API (DLAPI). Prior to joining the FDA, Barbara worked in pre-clinical drug discovery and development of anti-cancer agents at Abbott Laboratories/BASF Bioresearch Corporation in Worcester, MA.